Trial Profile
Cx621-0101 Phase I Clinical Trial in Healthy Volunteers to Evaluate the Feasibility and Safety of the Intralymphatic Administration Technique of Expanded Allogeneic Adipose-derived Stem Cells (eASCs)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Apr 2019
Price :
$35
*
At a glance
- Drugs CX 621 (Primary)
- Indications Autoimmune disorders; Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors TiGenix
- 31 Dec 2012 New trial record